New Analysis Compares Bone-Strengthening Medicines After Low-Trauma Fractures

Low-trauma fractures occur when bones break after a relatively minor fall or injury. They are often associated with osteoporosis, a condition that weakens bones and increases fracture risk.

After a fracture, patients may be prescribed antiresorptive medicines to reduce further bone loss. Two commonly used treatment approaches include nitrogen-containing bisphosphonates and denosumab.

Researchers in Australia compared outcomes among 15,099 adults aged 50 years or older who began osteoporosis treatment after a low-trauma fracture. The study used linked health records and a target-trial emulation approach to compare the two treatment groups.

The researchers found that starting nitrogen-containing bisphosphonates was associated with a higher risk of another fracture compared with denosumab in both men and women. However, there was no clear difference in all-cause mortality between the treatment groups.

These findings may help clinicians consider treatment selection and follow-up after fractures. However, the study is observational, and the results do not prove that one medicine is universally better for every patient.

Treatment decisions should consider fracture history, kidney function, other medical conditions, medication suitability, cost and the patient's overall risk profile. Patients should not change osteoporosis medication without consulting their treating doctor.